US SEC Filings Daily Market Digest — February 18, 2026

19-02-2026

Travelzoo filed an 8-K on February 19, 2026 (AccNo: 0001133311-26-000002, Size: 4 MB), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are explicitly stated in the provided filing information.

• ·Filing Accession Number: 0001133311-26-000002
• ·Filing Size: 4 MB

19-02-2026

The company filed a Form 8-K on February 19, 2026 (AccNo: 0001331465-26-000033), reporting under Item 2.03 the creation of a direct financial obligation through a Credit Agreement executed on the same date. No quantitative details such as transaction value, interest rates, maturity dates, covenants, or lenders are disclosed in the provided filing information. This is a single-item mandatory disclosure signaling new leverage, but lacking specifics, the financial impact and strategic context remain undetermined.

19-02-2026

Prothena Corp Public Ltd Co filed a Form 8-K on February 19, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure without quantified financial impacts or directional biases.

19-02-2026

LegalZoom.com, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001286139-26-000007), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results and related information. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details.

19-02-2026

Howard Hughes Holdings Inc. filed an 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement with attached exhibits. This is a multi-item filing typical for quarterly or annual earnings releases. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided information.

19-02-2026

AMN Healthcare Services Inc filed a Form 8-K on February 19, 2026 (AccNo: 0001142750-26-000003), reporting solely under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits details, transactions, metrics, or events are described in the provided filing information. This appears to be an informational filing with no disclosed quantitative impacts.

19-02-2026

CarGurus, Inc. filed an 8-K on February 19, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure.

• ·Filing Accession Number: 0001193125-26-059370
• ·Filing size: 1 MB
• ·Sector: not specified

19-02-2026

YETI Holdings, Inc. filed an 8-K on February 19, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This filing pertains to financial results with attached exhibits, likely including a press release or tables. No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are disclosed in the provided filing information.

19-02-2026

Quanta Services, Inc. filed a Form 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the filing description. This is a multi-item voluntary disclosure typical for earnings releases.

• ·Accession Number: 0001193125-26-058069
• ·File Size: 514 KB

19-02-2026

Expro Group Holdings N.V. filed a Form 8-K on February 19, 2026 (AccNo: 0001437749-26-004624), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics. No positive or negative performance indicators, guidance, or comparisons are detailed.

19-02-2026

Brady Corp filed an 8-K on February 19, 2026 (AccNo: 0000746598-26-000005), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

19-02-2026

Evergy, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001193125-26-058075, Size: 271 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other metrics are mentioned in the provided details. Analysis is limited without full filing content.

19-02-2026

Choice Hotels International Inc./DE filed an 8-K on February 19, 2026 (AccNo: 0001046311-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, comparisons, or other financial metrics were disclosed in the provided filing information. This appears to be a standard earnings release disclosure with attached exhibits.

19-02-2026

Praxis Precision Medicines, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001689548-26-000028), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, guidance, or quantitative financial data are disclosed in the provided filing description. This is an informational earnings-related disclosure with no directional performance indicators available.

19-02-2026

Tronox Holdings plc filed a Form 8-K on February 19, 2026 (AccNo: 0001140361-26-006120, Size: 852 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item earnings-related disclosure with no specific revenue, earnings, or other quantitative metrics disclosed in the provided filing information. No period-over-period comparisons, guidance, or operational details are available.

19-02-2026

Medical Properties Trust Inc filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058167), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data were explicitly stated in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance indicators.

19-02-2026

Century Aluminum Co filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009831), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits such as a press release. Specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED.

19-02-2026

19-02-2026

Gold.com, Inc. filed an 8-K on 2026-02-19 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are provided.

19-02-2026

BETA Technologies, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

19-02-2026

DEERE & CO filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information.

19-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001062993-26-001059, Size: 514 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the nature of the other events or the content of any exhibits. No quantitative metrics, financial impacts, or directional changes are disclosed.

19-02-2026

EPAM Systems, Inc. filed a Form 8-K on 2026-02-19 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This represents a standard voluntary earnings-related disclosure with no directional financial data available.

19-02-2026

AEMETIS, INC filed a Form 8-K on February 19, 2026, under Item 5.03 reporting amendments to Articles of Incorporation or Bylaws or change in fiscal year, Item 5.07 on submission of matters to a vote of security holders, Item 8.01 on other events, and Item 9.01 on financial statements and exhibits. No specific details, numerical data, outcomes, or impacts from these items are disclosed. This is a multi-item informational filing with no quantified financial or operational metrics provided.

19-02-2026

Delek US Holdings, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative data or directional implications provided.

19-02-2026

Cardinal Infrastructure Group Inc. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers results of operations and financial condition (Item 2.02), creation of financial obligations (Item 2.03), unregistered sales of equity securities (Item 3.02), changes in directors or officers (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details including parties, deal terms, financial metrics, positives, negatives, or impacts are NOT_DISCLOSED.

• ·AccNo: 0001213900-26-018087
• ·File size: 10 MB
• ·Event date and filing date: 2026-02-19
• ·Sector: NOT_DISCLOSED

19-02-2026

Figure Technology Solutions, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009377), reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, or specific details on the modifications, amendments, events, or exhibits disclosed in the provided information. No positive or negative performance metrics are mentioned.

19-02-2026

Aptevo Therapeutics Inc. filed an 8-K on February 19, 2026, reporting under Item 5.07: Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting were disclosed. No specific matters voted on, vote outcomes, numerical data, or financial metrics are mentioned in the filing summary. This is purely informational with no positive or negative performance metrics provided.

19-02-2026

CVB Financial Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including affected positions, individuals involved, reasons for change, or any quantitative terms were provided in the filing summary. Sector is not specified.

19-02-2026

FG Nexus Inc. filed an 8-K on February 19, 2026 (AccNo: 0001493152-26-007371, Size: 292 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure primarily driven by Regulation FD requirements, with no specific transaction details, financial metrics, positive or negative changes, or events disclosed in the provided filing information. No quantitative impacts or period-over-period comparisons are mentioned.

19-02-2026

Lemonade, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001691421-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This represents a standard voluntary earnings-related disclosure without detailed performance data.

19-02-2026

Edison International filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. The filing is 10 MB in size, indicating potential exhibits such as presentations or documents. No financial metrics, transactions, positive or negative changes, or other quantitative details are explicitly stated.

19-02-2026

MarketWise, Inc. filed a Form 8-K on February 19, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material nonpublic information to comply with Regulation FD, and Item 9.01 Financial Statements and Exhibits, likely attaching related documents such as a press release or presentation. No specific details on the content of the disclosure, financial metrics, transactions, positive or negative performance indicators, period-over-period changes, or other quantitative data are provided in the filing summary. This is a multi-item informational filing with no disclosed directional implications.

19-02-2026

Rivulet Entertainment, Inc. filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item mandatory filing, likely timely as filed same day as event date. No details on agreement terms, transaction value, financial impacts, or strategic rationale are disclosed.

19-02-2026

ADDENTAX GROUP CORP. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure with no positive or negative metrics reported.

19-02-2026

Targa Resources Corp. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058040), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, with no specific revenue, earnings, guidance, or period-over-period metrics provided in the filing summary. No positive or negative financial changes, transaction values, or operational details are disclosed.

19-02-2026

Hims & Hers Health, Inc. filed a Form 8-K on 2026-02-19 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates significant events but provides no specific details on transaction terms, financial impacts, or directions. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

19-02-2026

KEEMO Fashion Group Ltd filed an 8-K on February 19, 2026, reporting under Item 5.01 changes in control of the registrant. Item 9.01 discloses financial statements and exhibits. No specific details on the parties involved, transaction value, strategic implications, or financial impacts are provided.

19-02-2026

CenterPoint Energy Inc. filed an 8-K on February 19, 2026 (AccNo: 0001130310-26-000010, Size: 9 MB), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

19-02-2026

Gentherm Inc filed a Form 8-K on February 19, 2026 (AccNo: 0001193125-26-058037), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.

19-02-2026

Donegal Group Inc filed an 8-K on February 19, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing summary. This appears to be a standard earnings-related disclosure without quantified financial metrics.

19-02-2026

TechnipFMC plc filed a Form 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.

19-02-2026

Garrett Motion Inc. filed an 8-K on 2026-02-19 under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 attaching Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are mentioned in the provided filing details. This appears to be a standard voluntary earnings-related disclosure without disclosed directional performance indicators.

19-02-2026

Wheels Up Experience Inc. filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with attached financials.

19-02-2026

DT Midstream, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006115), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but specific metrics such as revenue, earnings, or guidance are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or guidance revisions are provided in the filing excerpt.

19-02-2026

Americold Realty Trust filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009471), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard earnings-related disclosure with no directional performance indicators available.

19-02-2026

UL Solutions Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001901440-26-000003, Size: 567 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative performance details available.

19-02-2026

Pediatrix Medical Group, Inc. filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

19-02-2026

Etsy Inc filed a Form 8-K on February 19, 2026 (AccNo: 0001370637-26-000017), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without quantified metrics.

19-02-2026

UPBOUND GROUP, INC. filed a Form 8-K on February 19, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing is standard for earnings releases but contains no specific quantitative financial metrics, guidance, or performance comparisons in the provided details. No positive, negative, or flat metrics were detailed.

19-02-2026

Visteon Corp filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This multi-item filing represents a standard voluntary earnings-related disclosure with no directional performance data available.

19-02-2026

N-able, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001834488-26-000004), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified financial metrics.

19-02-2026

D-Wave Quantum Inc. filed an 8-K on February 19, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events detailed in the provided filing information. Critical details such as core events, dollar values, or guidance are NOT_DISCLOSED.

19-02-2026

Wayfair Inc. filed an 8-K on 2026-02-19 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

19-02-2026

Appian Corp filed an 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a disclosure of financial results. This is a multi-item filing typical for earnings releases. No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information.

• ·Multi-item 8-K filing (Items 2.02, 8.01, 9.01)
• ·AccNo: 0001441683-26-000008
• ·File size: 1 MB
• ·Sector: not specified

19-02-2026

Bandwidth Inc. filed an 8-K on February 19, 2026 (AccNo: 0001514416-26-000014, Size: 561 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.

• ·Filing Accession Number: 0001514416-26-000014
• ·Event Type: Financial Results
• ·Source: us_sec

19-02-2026

Madrigal Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing details provided. This is a standard multi-item disclosure for financial results with all quantitative metrics NOT_DISCLOSED.

19-02-2026

Insmed Inc filed an 8-K on February 19, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with exhibits under Item 9.01. No specific details on the officer position affected, whether it was an appointment or resignation, reasons for the change, or any financial metrics from the results of operations are disclosed. No quantitative data, named executives, or scheduled events are mentioned.

19-02-2026

Cushman & Wakefield Ltd. filed an 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or transaction details are mentioned.

19-02-2026

Walmart Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0000104169-26-000032, Size: 66 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits) as part of its financial results disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related 8-K with attached exhibits.

19-02-2026

Occidental Petroleum Corp filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. The filing size is 266 KB with Accession Number 0000950157-26-000166.

19-02-2026

Laureate Education, Inc. filed an 8-K on 2026-02-19 disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a multi-item earnings-related disclosure.

• ·AccNo: 0001628280-26-009478
• ·File size: 7 MB
• ·Sector: not specified

19-02-2026

Six Flags Entertainment Corporation filed a Form 8-K on February 19, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative details available.

19-02-2026

LKQ Corp filed a Form 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics were disclosed in the filing summary provided. This is a standard disclosure for earnings-related information without detailed performance data.

19-02-2026

INTERNATIONAL BATTERY METALS LTD. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058107), reporting Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
• ·Filing size: 296 KB
• ·Critical financial details such as revenue, earnings, or guidance NOT_DISCLOSED

19-02-2026

Alight, Inc., a Delaware corporation, filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009483, Size: 535 KB), furnishing Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits) to disclose financial results. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

19-02-2026

Integrated Wellness Acquisition Corp filed an 8-K on 2026-02-19 under Item 8.01 Other Events announcing a Merger/Acquisition event. No quantitative metrics, financial terms, parties involved, deal structure, valuation, synergies, regulatory details, or shareholder impacts are disclosed. Sector is not specified.

19-02-2026

Kindly MD, Inc. filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, or other quantitative details are disclosed in the provided filing information. Sector is not specified.

19-02-2026

Allstate Corp filed an 8-K on February 19, 2026 (AccNo: 0000899051-26-000029, Size: 327 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material non-public information with attached exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing information.

19-02-2026

Beeline Holdings, Inc. filed a Form 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details of the disclosure, financial metrics, transactions, or events are provided in the filing summary. No quantitative data, positive or negative metrics, or material impacts are explicitly stated.

19-02-2026

News Corp filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative data or directional implications mentioned.

19-02-2026

Armstrong World Industries Inc filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058141), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial impacts, or exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with no quantitative metrics or directional performance indicators mentioned.

19-02-2026

ATI Inc filed an 8-K on February 19, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This appears to be an informational filing with no quantitative metrics or directional impacts provided.

19-02-2026

Upstart Holdings, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001647639-26-000033, size 162 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative metrics or directional information available.

19-02-2026

Orion Properties Inc. filed a multi-item Form 8-K on February 19, 2026, reporting entry into a new material definitive agreement (Item 1.01) while terminating an existing material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, financial impacts, or strategic rationales were disclosed in the filing summary. Item 9.01 references financial statements and exhibits, but specifics are not provided.

19-02-2026

Allarity Therapeutics, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of any financial statements and exhibits are disclosed in the provided filing information. This multi-item filing is informational in nature with no quantified metrics or directional impacts provided.

19-02-2026

Talkspace, Inc. filed an 8-K on 2026-02-19 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, or period-over-period comparisons are disclosed in the provided filing information. Critical financial details such as guidance or quantitative impacts are NOT_DISCLOSED.

19-02-2026

Traws Pharma, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing information. This is a multi-item informational filing with no quantified metrics or directional impacts provided.

19-02-2026

Cassava Sciences Inc filed an 8-K on February 19, 2026, disclosing under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core events, financial impacts, or quantitative metrics are explicitly stated in the provided filing information. This appears to be a multi-item informational filing with no directional financial data disclosed.

19-02-2026

Getty Images Holdings, Inc. filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the attached exhibits provided in the summary. No financial metrics, transactions, or performance data are disclosed.

19-02-2026

Integer Holdings Corp filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details in the available information. No positive or negative financial changes are explicitly stated.

19-02-2026

Cocrystal Pharma, Inc. filed a Form 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the disclosure, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary filing to publicly disclose potentially material information.

19-02-2026

Radian Group Inc filed a Form 8-K on 2026-02-19 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

19-02-2026

Athene Holding Ltd. filed a Form 8-K on 2026-02-19 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were mentioned in the filing summary. All quantitative financial data is NOT_DISCLOSED.

19-02-2026

Cardio Diagnostics Holdings, Inc. filed an 8-K on February 19, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. The filing size is 3 MB with AccNo 0001079973-26-000239.

19-02-2026

Mastech Digital, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058135), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or strategic impacts are provided in the filing summary.

19-02-2026

SharpLink Gaming, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001493152-26-007427, Size: 242 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information via Reg FD, other events, and attached exhibits, but specific details on events, transactions, financial metrics, or impacts are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or scheduled events mentioned.

19-02-2026

GATX Corp filed a Form 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing metadata. This is a multi-item informational filing typical for quarterly earnings releases.

19-02-2026

Worksport Ltd filed a Form 8-K on February 19, 2026 (AccNo: 0001493152-26-007428, Size: 232 KB), reporting under Item 7.01 Regulation FD Disclosure, which typically involves voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents. No quantitative financial metrics, transactions, period-over-period comparisons, positive or negative changes, or operational details are explicitly stated in the provided filing summary. No scheduled events, guidance, or other key data points are disclosed.

19-02-2026

IDACORP INC filed a Form 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

19-02-2026

Lucky Strike Entertainment Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative data such as compensation amounts are provided in the filing excerpt. Sector is not specified.

19-02-2026

Global Payments Inc filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017297, size 256 KB) reporting under Item 8.01 Other Events. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing summary. No positive, negative, or flat performance indicators are mentioned.

19-02-2026

Microbot Medical Inc. filed an 8-K on February 19, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This is an informational filing with no directional financial impact evident.

19-02-2026

COMPASS Pathways plc filed a Form 8-K on 2026-02-19 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.

19-02-2026

Apollo Global Management, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001858681-26-000010, Size: 193 KB) reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, guidance changes, or operational updates are explicitly stated in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or directional implications disclosed.

19-02-2026

Heritage Distilling Holding Company, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (AccNo: 0001788230-26-000015, size 160 KB). No financial metrics, transactions, guidance, or quantitative data are disclosed in the filing summary. This appears to be an informational voluntary disclosure with attached exhibits.

19-02-2026

Bluerock Homes Trust, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No quantitative financial metrics, transactions, or performance comparisons are provided.

19-02-2026

Energy Services of America Corp filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017301, Size: 513 KB), disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction size, parties, financial impacts, or quantitative metrics are provided in the filing summary. This represents a multi-item filing with no disclosed positive or negative performance indicators.

19-02-2026

POOL CORP filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits likely including press releases or presentations.

• ·AccNo: 0001193125-26-058288
• ·File size: 897 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Paycom Software, Inc. filed an 8-K on 2026-02-19 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on affected positions, appointment/resignation reasons, amendments, or disclosures are provided in the filing summary. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

19-02-2026

ASP Isotopes Inc. filed a Form 8-K on 2026-02-19 disclosing under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with file size 163 KB and AccNo 0001477932-26-000899. This is a multi-item voluntary disclosure typical for sharing material information via Reg FD without specified financial metrics, transactions, or events. No quantitative data, period-over-period comparisons, or directional impacts are detailed.

19-02-2026

NextTrip, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the filing summary provided. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

19-02-2026

Plumas Bancorp filed an 8-K on February 19, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data or period-over-period comparisons mentioned.

19-02-2026

PMGC Holdings Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018189, Size: 223 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with voluntary disclosure under Reg FD, likely including a press release or presentation as an exhibit, but no specific details, financial metrics, transactions, or quantitative data are disclosed in the filing summary. No positive or negative performance metrics are mentioned.

19-02-2026

Bitcoin Depot Inc. filed a Form 8-K on 2026-02-19 reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of modifications, amendments, disclosures, or events provided. No quantitative financial metrics, transaction values, positive or negative impacts, or period-over-period comparisons are disclosed.

19-02-2026

Old National Bancorp filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on officers affected, reasons for changes, amendment contents, or other events are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

19-02-2026

NightFood Holdings, Inc. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No quantitative metrics, parties, deal terms, or strategic details are provided in the filing summary. Sector is not specified.

19-02-2026

SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 19, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No financial metrics, transaction details, or further specifics on the accountant change provided.

19-02-2026

Tectonic Financial, Inc. filed an 8-K on February 19, 2026, under Item 8.01 Other Events. No specific details of the event, financial metrics, or quantitative data are disclosed in the provided filing information. This is a voluntary disclosure with no mentioned positive or negative impacts.

19-02-2026

Flutter Entertainment plc filed a Form 8-K on 2026-02-19 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of potentially material non-public information with attached exhibits. This is a multi-item filing with no specific details on events, transactions, or financial metrics provided in the summary. No quantitative data or period-over-period comparisons are disclosed.

• ·AccNo: 0001193125-26-058594
• ·File size: 143 KB

19-02-2026

Lottery.com Inc. filed a Form 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or metrics are disclosed.

19-02-2026

Core Scientific, Inc. filed a Form 8-K on February 19, 2026, under Items 1.01, 5.02, and 9.01, disclosing entry into a material definitive agreement and matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, personnel names, or other specific details are provided in the filing summary.

19-02-2026

AppTech Payments Corp. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, financial impact, or strategic rationale are provided. This is a multi-item mandatory filing with no quantitative metrics, comparisons, or forward-looking statements mentioned.

• ·AccNo: 0001683168-26-001173
• ·Filing size: 385 KB
• ·Sector: not specified

19-02-2026

PAMT CORP filed an 8-K on February 19, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition, indicating an announcement of financial results. Item 9.01 references attached Financial Statements and Exhibits, likely including a press release. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information.

19-02-2026

QNB Corp. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059013), reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on vote outcomes, events, or exhibits provided in the summary. No quantitative metrics, positive or negative changes, or financial impacts are disclosed.

19-02-2026

BOK Financial Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are disclosed.

19-02-2026

Quarta-Rad, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial impacts are provided. No quantitative metrics, performance comparisons, or other material updates are mentioned.

19-02-2026

Black Hawk Acquisition Corp filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific deal terms, parties, valuations, financial metrics, positive or negative changes, or other quantitative details are disclosed.

19-02-2026

ConnectM Technology Solutions, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017517, Size: 4 MB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses material non-public information publicly and attaches relevant exhibits. No specific quantitative metrics, transactions, financial impacts, or directional details are disclosed.

19-02-2026

Five9, Inc. filed an 8-K on 2026-02-19 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

19-02-2026

EVERTEC, Inc. filed a Form 8-K on February 19, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, financial metrics, transactions, or impacts provided in the filing summary. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

19-02-2026

WD-40 Company filed an 8-K on February 19, 2026 (AccNo: 0000105132-26-000016, Size: 397 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any quantitative financial impacts are provided in the filing summary. This appears to be an informational disclosure with no mentioned positive or negative performance metrics.

19-02-2026

Universal Display Corp filed an 8-K on February 19, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no detailed performance data available.

19-02-2026

ICU Medical Inc./DE filed an 8-K on February 19, 2026 (AccNo: 0000883984-26-000007), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure without detailed performance data.

19-02-2026

OLIN Corp filed an 8-K on February 19, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, guidance, or performance comparisons are disclosed in the filing summary. Critical details such as dollar values, percentages, or scheduled events are not provided.

19-02-2026

NewtekOne, Inc. filed an 8-K on February 19, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 8.01 reports other events. No specific transaction details, dollar values, strategic context, or other quantitative metrics are disclosed.

19-02-2026

MIDDLESEX WATER CO filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009722), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. Sector details are not specified.

19-02-2026

Karyopharm Therapeutics Inc. filed an 8-K on February 19, 2026, specifically under Item 5.07 reporting the submission of matters to a vote of security holders, likely results from a shareholder meeting. No specific vote outcomes, proposals, share counts, or other quantitative details are disclosed. This is a routine informational disclosure with no financial metrics or strategic implications provided.

19-02-2026

Essential Properties Realty Trust, Inc. filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No positive or negative metrics, comparisons, or impacts are mentioned.

19-02-2026

Ategrity Specialty Insurance Co Holdings filed a Form 8-K on February 19, 2026, under Item 8.01 Other Events. This is a single-item voluntary disclosure with no specific details on the event, transaction, or financial impacts provided in the filing metadata. No quantitative metrics, comparisons, or scheduled events are disclosed.

19-02-2026

Merchants Bancorp filed a Form 8-K on February 19, 2026 (AccNo: 0001104659-26-017537, Size: 314 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibit contents are disclosed. No positive or negative metrics are mentioned.

• ·AccNo: 0001104659-26-017537

19-02-2026

Tandem Diabetes Care Inc filed an 8-K on February 19, 2026 (AccNo: 0001438133-26-000009), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are detailed in the provided filing information. Sector is not specified.

• ·Filing size: 550 KB

19-02-2026

Spyre Therapeutics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001636282-26-000022, Size: 294 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is an informational disclosure typical for earnings releases, with no positive or negative performance indicators available.

• ·Sector: not specified
• ·Source: us_sec

19-02-2026

Alarm.com Holdings, Inc. filed an 8-K on 2026-02-19 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information.

19-02-2026

WillScot Holdings Corp filed a Form 8-K on February 19, 2026 (AccNo: 0001647088-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits attached. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is an informational disclosure typical for earnings releases, with no positive or negative metrics available for balanced assessment.

19-02-2026

19-02-2026

Newmont Corp /DE/ filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or quantitative metrics are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed financial data provided.

19-02-2026

Savers Value Village, Inc. filed a Form 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons were mentioned.

19-02-2026

MANGOCEUTICALS, INC. filed a Form 8-K on February 19, 2026 (AccNo: 0001493152-26-007468, Size: 237 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material nonpublic information with attached exhibits, but no specific transaction details, financial metrics, positive or negative changes, or performance data are disclosed in the filing metadata. No quantitative impacts, guidance revisions, or scheduled events are mentioned.

19-02-2026

Workiva Inc filed an 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted numerical data.

• ·Sector: NOT_DISCLOSED
• ·AccNo: 0001445305-26-000015
• ·File size: 624 KB

19-02-2026

FutureTech II Acquisition Corp. filed an 8-K on 2026-02-19 (AccNo: 0001493152-26-007470, Size: 255 KB) disclosing changes in its certifying accountant under Item 4.01. Item 9.01 covers financial statements and exhibits. No merger/acquisition details, financial metrics, positive or negative changes, or other quantitative data are mentioned.

19-02-2026

Sprouts Farmers Market, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This appears to be a routine governance disclosure without additional context on implications.

19-02-2026

Texas Roadhouse, Inc. filed an 8-K on 2026-02-19 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, and any financial metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or scheduled events are provided in the filing summary.

19-02-2026

CIMG Inc. filed an 8-K on February 19, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No additional details, financial metrics, reasons for the change, or quantitative data are provided.

19-02-2026

Processa Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, or financial impacts from the termination were provided.

19-02-2026

Planet Green Holdings Corp. filed an 8-K on 2026-02-19 reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which is a material negative event signaling non-compliance with exchange requirements. The filing is multi-item, also including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, impacts, or other details disclosed.

19-02-2026

19-02-2026

Inseego Corp. filed an 8-K on February 19, 2026 (AccNo: 0001683168-26-001189), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector details are not specified.

19-02-2026

Travere Therapeutics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001438533-26-000013), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a multi-item mandatory disclosure typical for earnings releases.

19-02-2026

Armada Hoffler Properties, Inc. filed an 8-K on 2026-02-19 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year). This is a multi-item mandatory filing with no specific details on the agreement, amendments, transaction value, financial impacts, or quantitative metrics disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.

19-02-2026

Ardelyx, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001437402-26-000012), reporting under Item 2.02 its results of operations and financial condition, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on financial results with no specific revenue, earnings, guidance, or other quantitative metrics disclosed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or material financial impacts are detailed.

19-02-2026

QCR Holdings Inc filed an 8-K on February 19, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is an informational filing with critical content missing.

19-02-2026

Rimini Street, Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. Specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED.

• ·AccNo: 0001635282-26-000015
• ·File size: 485 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

19-02-2026

Candel Therapeutics, Inc. filed a Form 8-K on 2026-02-19 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, quantitative metrics, transaction values, financial results, or period-over-period comparisons are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks substantive content for directional assessment.

19-02-2026

Green Brick Partners, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009698, size 192 KB), reporting solely under Item 8.01 Other Events. No details on the nature of the events, financial metrics, transactions, or impacts are disclosed. No positive or negative metrics are mentioned.

19-02-2026

PORTLAND GENERAL ELECTRIC CO /OR/ filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the financial statements and exhibits are disclosed. No quantitative metrics, transactions, or scheduled events are mentioned.

19-02-2026

First Solar, Inc. filed an 8-K on February 19, 2026, reporting entry into a material definitive agreement (Item 1.01) and termination of another material definitive agreement (Item 1.02), while also disclosing the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or financial impacts are disclosed, resulting in mixed implications from potential strategic shifts offset by new obligations.

19-02-2026

bioAffinity Technologies, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001493152-26-007464, Size: 344 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative data or directional implications provided.

19-02-2026

Comfort Systems USA Inc filed an 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed. Sector is not specified.

19-02-2026

Opus Genetics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001140361-26-006176), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative metrics, transaction values, period-over-period comparisons, or financial impacts disclosed in the provided information. No positive or negative performance indicators are mentioned.

19-02-2026

Park Dental Partners, Inc. filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, or period-over-period comparisons are disclosed.

• ·Accession Number: 0001104659-26-017525
• ·Filing size: 274 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Weave Communications, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001609151-26-000005, Size: 548 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a voluntary disclosure of financial results with no specific revenue, earnings, guidance, or period-over-period metrics disclosed in the provided filing summary. No positive or negative financial changes are detailed.

19-02-2026

PERDOCEO EDUCATION Corp filed an 8-K on 2026-02-19 disclosing an officer change event, with Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, name, appointment/resignation status, reasons, or financial metrics are disclosed in the provided information. No positive or negative metrics are mentioned.

19-02-2026

Inmune Bio, Inc. filed a Form 8-K on February 19, 2026, disclosing information under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are provided in the filing summary. No positive, negative, or flat performance metrics are mentioned.

19-02-2026

D. Boral Acquisition I Corp. filed an 8-K on 2026-02-19 under AccNo 0001213900-26-018401 (430 KB), disclosing other events under Item 8.01 related to a merger/acquisition and attaching financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, terms, or financial metrics are provided in the filing summary. Sector is not specified.

19-02-2026

Federal Agricultural Mortgage Corp filed an 8-K on February 19, 2026 (AccNo: 0000845877-26-000016), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but specific revenue, earnings, balance sheet changes, or performance metrics are NOT_DISCLOSED. No positive, negative, or flat metrics are provided in the available information.

19-02-2026

AMERICAN COASTAL INSURANCE Corp filed an 8-K on 2026-02-19 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided information. This is a multi-item filing related to financial results announcement.

19-02-2026

GRAIL, Inc. filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or transaction details are mentioned in the provided filing information. All quantitative data and performance indicators are NOT_DISCLOSED.

19-02-2026

DeFi Development Corp. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative impacts are disclosed. The filing size is 260 KB with AccNo 0001213900-26-018400.

19-02-2026

Ryerson Holding Corp filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, period-over-period changes, or other quantitative details are provided in the filing summary.

• ·AccNo: 0001193125-26-059448
• ·Filing size: 16 MB
• ·Event Type: Financial Results

19-02-2026

Hamilton Insurance Group, Ltd. filed a Form 8-K on 2026-02-19 disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative data are detailed in the provided filing information. This multi-item filing provides standard earnings-related disclosures with exhibits likely containing detailed results.

19-02-2026

AXT INC filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are explicitly stated in the provided filing information. This is a multi-item, standard financial results disclosure with all quantitative metrics NOT_DISCLOSED.

19-02-2026

Casella Waste Systems Inc filed an 8-K on 2026-02-19 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. All detailed results are NOT_DISCLOSED.

19-02-2026

BayCom Corp filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the content of the exhibits provided in the summary. No financial metrics, transactions, or quantitative impacts are disclosed.

19-02-2026

Bio-Rad Laboratories, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0000012208-26-000012, size 196 KB), reporting solely under Item 7.01 for Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative data are disclosed. This is a voluntary, single-item filing with no mentioned positive or negative impacts.

19-02-2026

Copart Inc filed an 8-K on 2026-02-19 reporting Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

19-02-2026

Cheetah Net Supply Chain Service Inc. filed a Form 8-K on February 19, 2026, reporting Item 3.02 Unregistered Sales of Equity Securities. No quantitative details such as transaction value, share count, pricing, or purchasers are disclosed. This is a single-item mandatory disclosure indicating private equity issuance, with no financial metrics or comparisons provided.

19-02-2026

Balchem Corp filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006184, Size: 152 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative impacts are disclosed.

19-02-2026

RE/MAX Holdings, Inc. filed an 8-K on 2026-02-19 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard earnings-related disclosure with no detailed data available for analysis.

19-02-2026

Akamai Technologies Inc filed an 8-K on February 19, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

19-02-2026

Barings BDC, Inc. filed an 8-K on 2026-02-19 under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the available information. No positive or negative metrics are detailed.

19-02-2026

SharonAI Holdings, Inc. filed a Form 8-K on 2026-02-19 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no further details provided on the nature of the agreement, events, or exhibits. No quantitative metrics, financial impacts, or transaction specifics are disclosed.

• ·Filing Accession Number: 0001829126-26-001479
• ·Filing size: 523 KB

19-02-2026

HARMONIC INC. filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This constitutes a multi-item filing for financial results announcement. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are explicitly stated in the provided filing details.

• ·AccNo: 0001193125-26-059434
• ·Filing size: 2 MB
• ·Sector: not specified

19-02-2026

Synopsys Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. No quantitative metrics, performance comparisons, or other financial data mentioned.

19-02-2026

EASTMAN KODAK CO filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, appointment or resignation status, reasons for change, timing, or individuals involved are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

19-02-2026

Generation Income Properties, Inc. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's nature, parties involved, dollar value, financial terms, or strategic implications are provided in the available filing summary. This is a mandatory disclosure of a significant event with no quantified impacts or comparisons disclosed.

19-02-2026

Floor & Decor Holdings, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009760), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements. No specific financial metrics, period-over-period changes, guidance, or other quantitative details were provided in the filing summary.

19-02-2026

Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.

19-02-2026

Live Oak Bancshares, Inc. filed a Form 8-K on February 19, 2026, specifically under Item 8.01 Other Events. No details on the nature of the other event, financial impacts, transactions, metrics, or strategic implications were disclosed in the filing description. This appears to be a single-item, likely voluntary disclosure with no quantitative data provided.

19-02-2026

PTC Therapeutics, Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are provided in the filing excerpt. No positive or negative metrics are explicitly stated.

19-02-2026

Employers Holdings, Inc. filed a Form 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a standard multi-item earnings-related disclosure with no directional financial data available.

19-02-2026

iRhythm Technologies, Inc. filed a Form 8-K on 2026-02-19 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing announcing financial results, with no specific revenue, earnings, guidance, or other metrics provided in the filing details. No positive or negative performance indicators are disclosed.

19-02-2026

Guardant Health, Inc. filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

19-02-2026

CTO Realty Growth, Inc. filed an 8-K on February 19, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, transaction details, or scheduled events are mentioned.

19-02-2026

ONTO INNOVATION INC. filed an 8-K on 2026-02-19 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other financial metrics are explicitly stated or quantified in the provided filing details. This is a multi-item informational filing typical for earnings releases.

• ·AccNo: 0001193125-26-059380
• ·Filing size: 737 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Dropbox, Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details.

19-02-2026

Sensata Technologies Holding plc filed a Form 8-K on February 19, 2026 (AccNo: 0001477294-26-000004, Size: 759 KB), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional financial details available.

• ·Multi-item 8-K filing (Items 2.02 and 9.01)
• ·Sector: NOT_DISCLOSED

19-02-2026

W. P. Carey Inc. filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017544), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing information. This multi-item filing indicates potentially significant developments but lacks substantive data for directional analysis.

19-02-2026

PG&E Corp filed a Form 8-K on February 19, 2026 (AccNo: 0001193125-26-059497, Size: 801 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of unspecified other events with attached financial statements or exhibits. No specific details on events, transactions, financial metrics, or impacts are disclosed.

19-02-2026

Live Nation Entertainment, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001335258-26-000007), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, positive or negative metrics, or other quantitative financial details are provided in the filing description. This appears to be a standard earnings-related disclosure with no extracted operational or strategic details.

19-02-2026

OneWater Marine Inc. filed a Form 8-K on February 19, 2026, reporting Item 5.07 regarding the submission of matters to a vote of security holders. No specific proposals, vote outcomes, numerical tallies, or other details are disclosed in the provided filing information. This is purely informational with no financial metrics or directional implications mentioned.

19-02-2026

Black Hills Corp (/SD/) filed an 8-K on 2026-02-19 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the Other Event, financial impacts, metrics, or exhibits content are disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data or directional indicators provided.

19-02-2026

Owens & Minor Inc./VA/ filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017541, Size: 1 MB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This is a multi-item filing focused on earnings-related disclosures.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
• ·Event type: Financial Results
• ·Sector: NOT_DISCLOSED

19-02-2026

Pulse Biosciences, Inc. filed an 8-K on 2026-02-19 reporting entry into a new material definitive agreement under Item 1.01 and termination of a prior material definitive agreement under Item 1.02, with exhibits provided under Item 9.01. This multi-item filing signals a potential strategic shift involving both a new commitment and the end of an existing one. Specific terms, parties, financial impacts, and strategic details are NOT_DISCLOSED.

19-02-2026

Amgen Inc filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, or financial implications are provided. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.

19-02-2026

ReposiTrak, Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or strategic updates are provided in the filing summary.

19-02-2026

Opendoor Technologies Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned. No positive or negative performance data, period-over-period comparisons, or other details are provided in the filing summary.

19-02-2026

Weyerhaeuser Co filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative financial impacts are disclosed. This is presented as a standard governance event without further context on positive or negative implications.

19-02-2026

National Bank Holdings Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

19-02-2026

Meritage Homes Corporation filed an 8-K on February 19, 2026 (AccNo: 0000833079-26-000016), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 reports other events, and Item 9.01 provides financial statements and exhibits. No specific details on the nature of the officer change, names, reasons, timing, or quantitative impacts are disclosed.

19-02-2026

Service Corp International filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content, financial statements, exhibits, or any quantitative metrics are explicitly stated. All transaction values, financial impacts, and performance metrics are NOT_DISCLOSED.

19-02-2026

Zynex Inc filed a Form 8-K on February 19, 2026, under Item 8.01 Other Events, indicating a voluntary disclosure of an unspecified event the company deems potentially important to security holders. No financial metrics, transaction details, strategic context, or quantitative impacts are mentioned. This single-item filing provides no directional information on performance.

19-02-2026

Viper Energy, Inc. filed an 8-K on 2026-02-19 disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, whether it was an appointment or resignation, reasons for the change, timing, or any quantitative data are disclosed. No positive or negative governance implications, board outcomes, or succession signals can be assessed due to lack of details.

19-02-2026

WORLD KINECT CORP filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other financial metrics were disclosed in the provided filing information. This appears to be a standard voluntary earnings release with no quantified positive or negative changes mentioned.

19-02-2026

Corcept Therapeutics Inc filed an 8-K on February 19, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event or contents of the exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with no quantitative metrics or directional implications mentioned.

19-02-2026

White Pearl Acquisition Corp. filed an 8-K on 2026-02-19 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. Specific details on deal structure, parties involved, valuation, terms, or financial impacts are NOT_DISCLOSED. No quantitative metrics, comparisons, or strategic rationale are provided in the filing summary.

19-02-2026

F&G Annuities & Life, Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

19-02-2026

Performance Food Group Co filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This is a multi-item mandatory disclosure with no quantified impacts available.

19-02-2026

indie Semiconductor, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059531), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no directional performance indicators available.

19-02-2026

Park Hotels & Resorts Inc. filed an 8-K on 2026-02-19 (AccNo: 0001617406-26-000003) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

• ·Filing size: 8 MB

19-02-2026

Rein Therapeutics, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059545), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, or compensatory terms are provided in the available information. Sector is not specified.

19-02-2026

NNN REIT, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059530, Size: 384 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer(s) involved, position affected, reason for change, or any quantitative metrics are NOT_DISCLOSED.

19-02-2026

Extra Space Storage Inc. filed an 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned. This appears to be a standard voluntary earnings-related disclosure.

19-02-2026

GoPro, Inc. filed an 8-K on 2026-02-19 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

• ·AccNo: 0001628280-26-009818
• ·Filing size: 221 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Bicara Therapeutics Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of information the company deems material.

19-02-2026

Marsh & McLennan Companies, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or exhibits are disclosed in the provided filing information. No financial metrics, transactions, or performance comparisons—positive, negative, or flat—are mentioned.

• ·AccNo: 0001193125-26-059544
• ·File Size: 442 KB

19-02-2026

iANTHUS CAPITAL HOLDINGS, INC. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059527, Size: 214 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements and exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with no quantitative metrics or directional financial impacts mentioned.

19-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative impacts were disclosed. No positive or negative metrics, performance comparisons, or governance implications were provided.

• ·Filing Accession Number: 0001213900-26-018446
• ·File Size: 469 KB
• ·Sector: not specified

19-02-2026

T-Mobile US, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. This is a multi-item filing with no quantitative metrics, transaction details, or directional impacts provided.

19-02-2026

19-02-2026

Metallus Inc. filed an 8-K on 2026-02-19 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators are mentioned.

19-02-2026

Lifeward Ltd. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impacts were disclosed. This is a multi-item mandatory filing with limited specifics provided.

19-02-2026

19-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative impacts are disclosed.

19-02-2026

YORK WATER CO filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure. No specific details on the disclosed information, financial metrics, transactions, or events are provided in the filing summary. This appears to be a single-item voluntary disclosure.

19-02-2026

Strawberry Fields REIT, Inc. filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard multi-item earnings-related disclosure with no directional performance indicators available.

19-02-2026

Valaris Ltd filed a Form 8-K on 2026-02-19 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were detailed in the provided filing information. This is a standard earnings-related disclosure without disclosed directional performance indicators.

19-02-2026

ON24 INC. filed a Form 8-K on February 19, 2026, specifically under Item 8.01 Other Events. No details on the core event, financial impacts, quantitative metrics, or other specifics are disclosed in the provided filing information.

19-02-2026

Boyd Gaming Corp filed an 8-K on February 19, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No quantitative data, named entities beyond the filer, or scheduled events are mentioned.

19-02-2026

RingCentral, Inc. filed a Form 8-K on 2026-02-19 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators are available.

19-02-2026

Select Water Solutions, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing information. This appears to be a multi-item informational filing with attached exhibits.

19-02-2026

Shutterstock, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary provided.

19-02-2026

Silvaco Group, Inc. filed an 8-K on February 19, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 references financial statements and exhibits. No specific details on the amendments, financial impacts, or quantitative metrics are disclosed.

19-02-2026

ManpowerGroup Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

• ·Filing accession number: 0001193125-26-059576
• ·Filing size: 607 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Hanover Bancorp, Inc. /MD filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics were provided. No positive or negative performance metrics were mentioned.

19-02-2026

Consolidated Edison Inc filed an 8-K on February 19, 2026 (AccNo: 0001047862-26-000028), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, comparisons, guidance, or other quantitative data were explicitly stated in the provided filing details. This appears to be a standard voluntary earnings-related disclosure with attached financial statements.

19-02-2026

Destra Multi-Alternative Fund filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details of the other event, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material impacts are mentioned.

19-02-2026

Select Medical Holdings Corp filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017585), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results, but no specific revenue, earnings, guidance, or period-over-period metrics are disclosed. No positive or negative financial changes, scheduled events, or transaction details are provided in the available information.

19-02-2026

Plexus Corp filed an 8-K on February 19, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 discloses financial statements and exhibits, likely including vote tallies. No specific vote outcomes, quantitative metrics, or other details provided in the filing summary.

19-02-2026

Chemours Co filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059564), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

• ·Filing date: 2026-02-19
• ·Accession Number: 0001193125-26-059564
• ·File size: 1 MB

19-02-2026

HCW Biologics Inc. filed a Form 8-K on February 19, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 8.01 other events. No specific details on the agreement, transaction terms, financial impacts, positive or negative metrics, or other quantitative data are disclosed in the provided filing information.

19-02-2026

Kentucky First Federal Bancorp filed an 8-K on 2026-02-19 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references Item 9.01 for financial statements and exhibits. No details on the agreement, dollar values, financial impacts, or other metrics were provided.

19-02-2026

VICOR CORP filed a Form 8-K on 2026-02-19 (AccNo: 0001193125-26-059563, Size: 224 KB) reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.

19-02-2026

urban-gro, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018473) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative metrics are mentioned.

19-02-2026

DOMO, INC. filed a Form 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosed information, financial metrics, transactions, or other events are provided in the filing summary. No positive or negative metrics are mentioned.

19-02-2026

Fidelity National Financial, Inc. filed a Form 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing description. This represents a standard mandatory earnings-related disclosure without detailed performance data available.

19-02-2026

Pinnacle West Capital Corp filed a Form 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 5.02 departure of directors/officers, election/appointment, or compensatory arrangements for certain officers. Item 9.01 lists financial statements and exhibits. No quantitative details, dollar values, or specific impacts were disclosed.

19-02-2026

19-02-2026

FIRST CAPITAL INC filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events, financial statements, or exhibits are NOT_DISCLOSED. This is a multi-item informational filing with no disclosed quantitative metrics, positive or negative performance indicators.

19-02-2026

Avalon GloboCare Corp. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, parties, values, or performance indicators are disclosed.

19-02-2026

Sow Good Inc. filed a multi-item Form 8-K on February 19, 2026, disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Item 9.01 references financial statements and exhibits. No quantitative details, transaction values, personnel names, or specific changes are disclosed.

• ·AccNo: 0001829126-26-001486
• ·File Size: 531 KB

19-02-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on February 19, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). This multi-item filing indicates a potentially strategic agreement offset by potentially dilutive equity sales, but specific terms, values, and impacts are NOT_DISCLOSED. No financial metrics, period-over-period changes, or guidance updates are mentioned.

19-02-2026

Getty Realty Corp (/MD/) filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059712), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material contract event.

19-02-2026

Spartacus Acquisition Corp. II filed an 8-K on 2026-02-19 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are disclosed. No quantitative metrics, positive or negative changes, or scheduled events are mentioned in the provided filing information.

19-02-2026

NexPoint Diversified Real Estate Trust filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No quantitative details such as transaction value, terms, parties, or financial impacts are disclosed in the provided filing summary. This multi-item filing signals a potentially significant financing event, but lacks specifics for impact assessment.

19-02-2026

Willow Lane Acquisition Corp. II filed an 8-K on February 19, 2026, disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition as a SPAC. Additional disclosures include unregistered sales of equity securities (Item 3.02), departures or elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, valuation, financial metrics, or performance comparisons are disclosed.

19-02-2026

Seagate Technology Holdings plc filed a Form 8-K on February 19, 2026, reporting unregistered sales of equity securities under Item 3.02, Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no quantitative details on transaction sizes, financial impacts, or event specifics provided. No positive or negative metrics are disclosed.

19-02-2026

VSEE Health, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001185185-26-000625), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement terms, parties, value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory disclosure with no quantitative data or performance metrics provided.

19-02-2026

i-80 Gold Corp. filed a Form 8-K on February 19, 2026, under Item 2.02 to disclose results of operations and financial condition. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing information. No positive or negative financial changes are disclosed.

19-02-2026

Expeditors International of Washington Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or financial metrics are disclosed.

19-02-2026

Camden Property Trust filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, which is a multi-item filing including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This appears to be a mandatory disclosure of material events.

19-02-2026

Zoomcar Holdings, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001213900-26-018508), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing includes voluntary disclosure under Reg FD, likely a press release or update, with attached exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing summary.

19-02-2026

Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, timing, or any quantitative financial metrics are provided in the available information. No positive or negative performance metrics, comparisons, or impacts are mentioned.